Here are some clinical trials that could send Big Pharma shares soaring, or crashing, in 2025. Eli Lilly. The world’s biggest ...
Look for renewed investment driven by lower interest rates in the new year, and a continued focus on late-stage assets, ...
The grand jury, convened at the request of Gov. Ron DeSantis, recommended policy changes including increasing transparency ...
China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.
New Republic on MSN13dOpinion
How Big Pharma Is Wrecking the Inflation Reduction ActThe industry’s intellectual property manipulations are stealing from your pockets—and limiting the benefits of the Biden ...
POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ('IGC Pharma' or the 'Company') announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...
Denali Therapeutics' DNL343 fails to slow ALS progression in phase 2/3 trial but shows safety and offers insights for future ...
The obesity market was a dominating force in 2024, with GLP-1 medications from Novo Nordisk and Eli Lilly becoming some of ...
Gene therapy firm Capsida Biotherapeutics is advancing the first of its AbbVie-partnered neurodegenerative disease therapies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback